Industry Research Reports

Home > Reports > Pharma & Healthcare > Oral Diabetes Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Oral Diabetes Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-05

Pages: 112 Pages

Report ld: 2127747

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Oral Diabetes Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Oral Diabetes Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Oral Diabetes Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Oral Diabetes Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Diabetes Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Diabetes Medicine by region & country, by Type, and by Application.

The Oral Diabetes Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Diabetes Medicine.

Market Segmentation

Report Metric
Details
Report Title
Oral Diabetes Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Oral Diabetes Medicine Companies Covered
Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda, AstraZeneca, Huadong Medicine, Eli Lilly and Company, Deyuan Pharmaceutical, Hengrui Medicine
Global Oral Diabetes Medicine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Diabetes Medicine Market, Segment by Type
DPP-4

GLP-1

SGLT-2
Global Oral Diabetes Medicine Market, Segment by Application
Type 1 Diabetes

Type 2 Diabetes
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Diabetes Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oral Diabetes Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oral Diabetes Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Oral Diabetes Medicine Product Introduction
    1.2 Global Oral Diabetes Medicine Market Size Forecast
        1.2.1 Global Oral Diabetes Medicine Sales Value (2019-2030)
        1.2.2 Global Oral Diabetes Medicine Sales Volume (2019-2030)
        1.2.3 Global Oral Diabetes Medicine Sales Price (2019-2030)
    1.3 Oral Diabetes Medicine Market Trends & Drivers
        1.3.1 Oral Diabetes Medicine Industry Trends
        1.3.2 Oral Diabetes Medicine Market Drivers & Opportunity
        1.3.3 Oral Diabetes Medicine Market Challenges
        1.3.4 Oral Diabetes Medicine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Oral Diabetes Medicine Players Revenue Ranking (2023)
    2.2 Global Oral Diabetes Medicine Revenue by Company (2019-2024)
    2.3 Global Oral Diabetes Medicine Players Sales Volume Ranking (2023)
    2.4 Global Oral Diabetes Medicine Sales Volume by Company Players (2019-2024)
    2.5 Global Oral Diabetes Medicine Average Price by Company (2019-2024)
    2.6 Key Manufacturers Oral Diabetes Medicine Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Oral Diabetes Medicine Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Oral Diabetes Medicine
    2.9 Oral Diabetes Medicine Market Competitive Analysis
        2.9.1 Oral Diabetes Medicine Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Oral Diabetes Medicine Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Diabetes Medicine as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 DPP-4
        3.1.2 GLP-1
        3.1.3 SGLT-2
    3.2 Global Oral Diabetes Medicine Sales Value by Type
        3.2.1 Global Oral Diabetes Medicine Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Oral Diabetes Medicine Sales Value, by Type (2019-2030)
        3.2.3 Global Oral Diabetes Medicine Sales Value, by Type (%) (2019-2030)
    3.3 Global Oral Diabetes Medicine Sales Volume by Type
        3.3.1 Global Oral Diabetes Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Oral Diabetes Medicine Sales Volume, by Type (2019-2030)
        3.3.3 Global Oral Diabetes Medicine Sales Volume, by Type (%) (2019-2030)
    3.4 Global Oral Diabetes Medicine Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Type 1 Diabetes
        4.1.2 Type 2 Diabetes
    4.2 Global Oral Diabetes Medicine Sales Value by Application
        4.2.1 Global Oral Diabetes Medicine Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Oral Diabetes Medicine Sales Value, by Application (2019-2030)
        4.2.3 Global Oral Diabetes Medicine Sales Value, by Application (%) (2019-2030)
    4.3 Global Oral Diabetes Medicine Sales Volume by Application
        4.3.1 Global Oral Diabetes Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Oral Diabetes Medicine Sales Volume, by Application (2019-2030)
        4.3.3 Global Oral Diabetes Medicine Sales Volume, by Application (%) (2019-2030)
    4.4 Global Oral Diabetes Medicine Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Oral Diabetes Medicine Sales Value by Region
        5.1.1 Global Oral Diabetes Medicine Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Oral Diabetes Medicine Sales Value by Region (2019-2024)
        5.1.3 Global Oral Diabetes Medicine Sales Value by Region (2025-2030)
        5.1.4 Global Oral Diabetes Medicine Sales Value by Region (%), (2019-2030)
    5.2 Global Oral Diabetes Medicine Sales Volume by Region
        5.2.1 Global Oral Diabetes Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Oral Diabetes Medicine Sales Volume by Region (2019-2024)
        5.2.3 Global Oral Diabetes Medicine Sales Volume by Region (2025-2030)
        5.2.4 Global Oral Diabetes Medicine Sales Volume by Region (%), (2019-2030)
    5.3 Global Oral Diabetes Medicine Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Oral Diabetes Medicine Sales Value, 2019-2030
        5.4.2 North America Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Oral Diabetes Medicine Sales Value, 2019-2030
        5.5.2 Europe Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Oral Diabetes Medicine Sales Value, 2019-2030
        5.6.2 Asia Pacific Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Oral Diabetes Medicine Sales Value, 2019-2030
        5.7.2 South America Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Oral Diabetes Medicine Sales Value, 2019-2030
        5.8.2 Middle East & Africa Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Oral Diabetes Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Oral Diabetes Medicine Sales Value
        6.2.1 Key Countries/Regions Oral Diabetes Medicine Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Oral Diabetes Medicine Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Oral Diabetes Medicine Sales Value, 2019-2030
        6.3.2 United States Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Oral Diabetes Medicine Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Oral Diabetes Medicine Sales Value, 2019-2030
        6.4.2 Europe Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Oral Diabetes Medicine Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Oral Diabetes Medicine Sales Value, 2019-2030
        6.5.2 China Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Oral Diabetes Medicine Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Oral Diabetes Medicine Sales Value, 2019-2030
        6.6.2 Japan Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Oral Diabetes Medicine Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Oral Diabetes Medicine Sales Value, 2019-2030
        6.7.2 South Korea Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Oral Diabetes Medicine Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Oral Diabetes Medicine Sales Value, 2019-2030
        6.8.2 Southeast Asia Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Oral Diabetes Medicine Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Oral Diabetes Medicine Sales Value, 2019-2030
        6.9.2 India Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Oral Diabetes Medicine Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Information
        7.1.2 Sanofi Introduction and Business Overview
        7.1.3 Sanofi Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Sanofi Oral Diabetes Medicine Product Offerings
        7.1.5 Sanofi Recent Development
    7.2 Biocon
        7.2.1 Biocon Company Information
        7.2.2 Biocon Introduction and Business Overview
        7.2.3 Biocon Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Biocon Oral Diabetes Medicine Product Offerings
        7.2.5 Biocon Recent Development
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Company Information
        7.3.2 Boehringer Ingelheim Introduction and Business Overview
        7.3.3 Boehringer Ingelheim Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Boehringer Ingelheim Oral Diabetes Medicine Product Offerings
        7.3.5 Boehringer Ingelheim Recent Development
    7.4 Merck & Co.
        7.4.1 Merck & Co. Company Information
        7.4.2 Merck & Co. Introduction and Business Overview
        7.4.3 Merck & Co. Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Merck & Co. Oral Diabetes Medicine Product Offerings
        7.4.5 Merck & Co. Recent Development
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Company Information
        7.5.2 Johnson & Johnson Introduction and Business Overview
        7.5.3 Johnson & Johnson Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Johnson & Johnson Oral Diabetes Medicine Product Offerings
        7.5.5 Johnson & Johnson Recent Development
    7.6 Novartis
        7.6.1 Novartis Company Information
        7.6.2 Novartis Introduction and Business Overview
        7.6.3 Novartis Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Novartis Oral Diabetes Medicine Product Offerings
        7.6.5 Novartis Recent Development
    7.7 Novo Nordisk
        7.7.1 Novo Nordisk Company Information
        7.7.2 Novo Nordisk Introduction and Business Overview
        7.7.3 Novo Nordisk Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Novo Nordisk Oral Diabetes Medicine Product Offerings
        7.7.5 Novo Nordisk Recent Development
    7.8 Takeda
        7.8.1 Takeda Company Information
        7.8.2 Takeda Introduction and Business Overview
        7.8.3 Takeda Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Takeda Oral Diabetes Medicine Product Offerings
        7.8.5 Takeda Recent Development
    7.9 AstraZeneca
        7.9.1 AstraZeneca Company Information
        7.9.2 AstraZeneca Introduction and Business Overview
        7.9.3 AstraZeneca Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 AstraZeneca Oral Diabetes Medicine Product Offerings
        7.9.5 AstraZeneca Recent Development
    7.10 Huadong Medicine
        7.10.1 Huadong Medicine Company Information
        7.10.2 Huadong Medicine Introduction and Business Overview
        7.10.3 Huadong Medicine Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Huadong Medicine Oral Diabetes Medicine Product Offerings
        7.10.5 Huadong Medicine Recent Development
    7.11 Eli Lilly and Company
        7.11.1 Eli Lilly and Company Company Information
        7.11.2 Eli Lilly and Company Introduction and Business Overview
        7.11.3 Eli Lilly and Company Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Eli Lilly and Company Oral Diabetes Medicine Product Offerings
        7.11.5 Eli Lilly and Company Recent Development
    7.12 Deyuan Pharmaceutical
        7.12.1 Deyuan Pharmaceutical Company Information
        7.12.2 Deyuan Pharmaceutical Introduction and Business Overview
        7.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Deyuan Pharmaceutical Oral Diabetes Medicine Product Offerings
        7.12.5 Deyuan Pharmaceutical Recent Development
    7.13 Hengrui Medicine
        7.13.1 Hengrui Medicine Company Information
        7.13.2 Hengrui Medicine Introduction and Business Overview
        7.13.3 Hengrui Medicine Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Hengrui Medicine Oral Diabetes Medicine Product Offerings
        7.13.5 Hengrui Medicine Recent Development

 8 Industry Chain Analysis
    8.1 Oral Diabetes Medicine Industrial Chain
    8.2 Oral Diabetes Medicine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Oral Diabetes Medicine Sales Model
        8.5.2 Sales Channel
        8.5.3 Oral Diabetes Medicine Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Oral Diabetes Medicine Market Trends
    Table 2. Oral Diabetes Medicine Market Drivers & Opportunity
    Table 3. Oral Diabetes Medicine Market Challenges
    Table 4. Oral Diabetes Medicine Market Restraints
    Table 5. Global Oral Diabetes Medicine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oral Diabetes Medicine Revenue Market Share by Company (2019-2024)
    Table 7. Global Oral Diabetes Medicine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Oral Diabetes Medicine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Oral Diabetes Medicine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Oral Diabetes Medicine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Oral Diabetes Medicine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Oral Diabetes Medicine
    Table 13. Global Oral Diabetes Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Diabetes Medicine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oral Diabetes Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Oral Diabetes Medicine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Oral Diabetes Medicine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Oral Diabetes Medicine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Oral Diabetes Medicine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Oral Diabetes Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Oral Diabetes Medicine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Oral Diabetes Medicine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Oral Diabetes Medicine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Oral Diabetes Medicine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Oral Diabetes Medicine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Oral Diabetes Medicine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Oral Diabetes Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Oral Diabetes Medicine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Oral Diabetes Medicine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Oral Diabetes Medicine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Oral Diabetes Medicine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Oral Diabetes Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Oral Diabetes Medicine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Oral Diabetes Medicine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Oral Diabetes Medicine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Oral Diabetes Medicine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Oral Diabetes Medicine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Oral Diabetes Medicine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Oral Diabetes Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Oral Diabetes Medicine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Oral Diabetes Medicine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Oral Diabetes Medicine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Oral Diabetes Medicine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Oral Diabetes Medicine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Oral Diabetes Medicine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Oral Diabetes Medicine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Oral Diabetes Medicine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Oral Diabetes Medicine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Oral Diabetes Medicine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Oral Diabetes Medicine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Oral Diabetes Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Oral Diabetes Medicine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Oral Diabetes Medicine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Oral Diabetes Medicine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Oral Diabetes Medicine Sales Volume, (2025-2030) & (K Units)
    Table 57. Sanofi Company Information
    Table 58. Sanofi Introduction and Business Overview
    Table 59. Sanofi Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Sanofi Oral Diabetes Medicine Product Offerings
    Table 61. Sanofi Recent Development
    Table 62. Biocon Company Information
    Table 63. Biocon Introduction and Business Overview
    Table 64. Biocon Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Biocon Oral Diabetes Medicine Product Offerings
    Table 66. Biocon Recent Development
    Table 67. Boehringer Ingelheim Company Information
    Table 68. Boehringer Ingelheim Introduction and Business Overview
    Table 69. Boehringer Ingelheim Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Boehringer Ingelheim Oral Diabetes Medicine Product Offerings
    Table 71. Boehringer Ingelheim Recent Development
    Table 72. Merck & Co. Company Information
    Table 73. Merck & Co. Introduction and Business Overview
    Table 74. Merck & Co. Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Merck & Co. Oral Diabetes Medicine Product Offerings
    Table 76. Merck & Co. Recent Development
    Table 77. Johnson & Johnson Company Information
    Table 78. Johnson & Johnson Introduction and Business Overview
    Table 79. Johnson & Johnson Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Johnson & Johnson Oral Diabetes Medicine Product Offerings
    Table 81. Johnson & Johnson Recent Development
    Table 82. Novartis Company Information
    Table 83. Novartis Introduction and Business Overview
    Table 84. Novartis Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Novartis Oral Diabetes Medicine Product Offerings
    Table 86. Novartis Recent Development
    Table 87. Novo Nordisk Company Information
    Table 88. Novo Nordisk Introduction and Business Overview
    Table 89. Novo Nordisk Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Novo Nordisk Oral Diabetes Medicine Product Offerings
    Table 91. Novo Nordisk Recent Development
    Table 92. Takeda Company Information
    Table 93. Takeda Introduction and Business Overview
    Table 94. Takeda Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Takeda Oral Diabetes Medicine Product Offerings
    Table 96. Takeda Recent Development
    Table 97. AstraZeneca Company Information
    Table 98. AstraZeneca Introduction and Business Overview
    Table 99. AstraZeneca Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. AstraZeneca Oral Diabetes Medicine Product Offerings
    Table 101. AstraZeneca Recent Development
    Table 102. Huadong Medicine Company Information
    Table 103. Huadong Medicine Introduction and Business Overview
    Table 104. Huadong Medicine Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Huadong Medicine Oral Diabetes Medicine Product Offerings
    Table 106. Huadong Medicine Recent Development
    Table 107. Eli Lilly and Company Company Information
    Table 108. Eli Lilly and Company Introduction and Business Overview
    Table 109. Eli Lilly and Company Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Eli Lilly and Company Oral Diabetes Medicine Product Offerings
    Table 111. Eli Lilly and Company Recent Development
    Table 112. Deyuan Pharmaceutical Company Information
    Table 113. Deyuan Pharmaceutical Introduction and Business Overview
    Table 114. Deyuan Pharmaceutical Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Deyuan Pharmaceutical Oral Diabetes Medicine Product Offerings
    Table 116. Deyuan Pharmaceutical Recent Development
    Table 117. Hengrui Medicine Company Information
    Table 118. Hengrui Medicine Introduction and Business Overview
    Table 119. Hengrui Medicine Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Hengrui Medicine Oral Diabetes Medicine Product Offerings
    Table 121. Hengrui Medicine Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Oral Diabetes Medicine Downstream Customers
    Table 125. Oral Diabetes Medicine Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Diabetes Medicine Product Picture
    Figure 2. Global Oral Diabetes Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oral Diabetes Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Oral Diabetes Medicine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Oral Diabetes Medicine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Oral Diabetes Medicine Report Years Considered
    Figure 7. Global Oral Diabetes Medicine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Oral Diabetes Medicine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Diabetes Medicine Revenue in 2023
    Figure 10. Oral Diabetes Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. DPP-4 Picture
    Figure 12. GLP-1 Picture
    Figure 13. SGLT-2 Picture
    Figure 14. Global Oral Diabetes Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Oral Diabetes Medicine Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Oral Diabetes Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Oral Diabetes Medicine Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Oral Diabetes Medicine Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Type 1 Diabetes
    Figure 20. Product Picture of Type 2 Diabetes
    Figure 21. Global Oral Diabetes Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Oral Diabetes Medicine Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Oral Diabetes Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Oral Diabetes Medicine Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Oral Diabetes Medicine Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Oral Diabetes Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Oral Diabetes Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Oral Diabetes Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Oral Diabetes Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Oral Diabetes Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Oral Diabetes Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Oral Diabetes Medicine Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Oral Diabetes Medicine Sales Volume (%), (2019-2030)
    Figure 38. United States Oral Diabetes Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Oral Diabetes Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Oral Diabetes Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Oral Diabetes Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Oral Diabetes Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Oral Diabetes Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Oral Diabetes Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Oral Diabetes Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Oral Diabetes Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Oral Diabetes Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Oral Diabetes Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Oral Diabetes Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Oral Diabetes Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Oral Diabetes Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Oral Diabetes Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 59. Oral Diabetes Medicine Industrial Chain
    Figure 60. Oral Diabetes Medicine Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Description

The global market for Oral Diabetes Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Oral Diabetes Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Oral Diabetes Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Oral Diabetes Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Diabetes Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Diabetes Medicine by region & country, by Type, and by Application.

The Oral Diabetes Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Diabetes Medicine.

Market Segmentation